Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2025 22:55 ET | Source: Annexon Biosciences BRISBANE, Calif., Nov.…
Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy
August 07, 2025 16:30 ET | Source: Annexon Biosciences New Pilot Appoints…
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
June 18, 2025 16:05 ET | Source: Annexon Biosciences Dr. Clark Brings…
